{"filter":{"phase":null,"status":null,"sponsor":null},"count":50,"items":[{"nct_id":"NCT06317649","brief_title":"Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Cancer Institute (NCI)","lead_sponsor_class":"NIH","start_date":"2024-09-27","primary_completion_date":"2029-05-15","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06317649","external_url":"https://clinicaltrials.gov/study/NCT06317649"},{"nct_id":"NCT07589712","brief_title":"Acute Effects of Proprioceptive Neuromuscular Facilitation on Hamstring-to-Quadriceps Strength Ratio","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Gümüşhane Universıty","lead_sponsor_class":"OTHER","start_date":"2025-03-05","primary_completion_date":"2025-04-15","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07589712","external_url":"https://clinicaltrials.gov/study/NCT07589712"},{"nct_id":"NCT04281381","brief_title":"Observing People With Desmoid-Type Fibromatosis","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","lead_sponsor_class":"OTHER","start_date":"2020-02-19","primary_completion_date":"2027-02-19","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT04281381","external_url":"https://clinicaltrials.gov/study/NCT04281381"},{"nct_id":"NCT06807398","brief_title":"Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer","phase":null,"study_type":"OBSERVATIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Francesco Montorsi","lead_sponsor_class":"OTHER","start_date":"2020-06-15","primary_completion_date":"2021-04-10","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06807398","external_url":"https://clinicaltrials.gov/study/NCT06807398"},{"nct_id":"NCT02710253","brief_title":"Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"M.D. Anderson Cancer Center","lead_sponsor_class":"OTHER","start_date":"2016-05-25","primary_completion_date":"2027-05-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT02710253","external_url":"https://clinicaltrials.gov/study/NCT02710253"},{"nct_id":"NCT07590375","brief_title":"Topical Phenytoin for Management of Gingival Recession","phase":"PHASE2,PHASE3","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Cairo University","lead_sponsor_class":"OTHER","start_date":"2026-06-01","primary_completion_date":"2027-09-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590375","external_url":"https://clinicaltrials.gov/study/NCT07590375"},{"nct_id":"NCT07589842","brief_title":"Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","lead_sponsor_class":"OTHER","start_date":"2026-10-01","primary_completion_date":"2028-11-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07589842","external_url":"https://clinicaltrials.gov/study/NCT07589842"},{"nct_id":"NCT05063331","brief_title":"Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"University Hospitals Cleveland Medical Center","lead_sponsor_class":"OTHER","start_date":"2021-12-15","primary_completion_date":"2029-05-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT05063331","external_url":"https://clinicaltrials.gov/study/NCT05063331"},{"nct_id":"NCT06331429","brief_title":"Emoticare: Serious Game for the Adaptation to the Disease of Adolescents With Type 1 Diabetes Mellitus.","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University of Valencia","lead_sponsor_class":"OTHER","start_date":"2024-07-22","primary_completion_date":"2024-09-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06331429","external_url":"https://clinicaltrials.gov/study/NCT06331429"},{"nct_id":"NCT06377462","brief_title":"Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Technische Universität Dresden","lead_sponsor_class":"OTHER","start_date":"2024-03-13","primary_completion_date":"2029-12-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06377462","external_url":"https://clinicaltrials.gov/study/NCT06377462"},{"nct_id":"NCT07590297","brief_title":"Translation, Cross-cultural Adaptation, and Validation of the FPI-6 in Spain","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Paloma López Ros","lead_sponsor_class":"OTHER","start_date":"2026-05-16","primary_completion_date":"2028-05","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590297","external_url":"https://clinicaltrials.gov/study/NCT07590297"},{"nct_id":"NCT04566328","brief_title":"Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","lead_sponsor_class":"NETWORK","start_date":"2021-02-24","primary_completion_date":"2027-12-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT04566328","external_url":"https://clinicaltrials.gov/study/NCT04566328"},{"nct_id":"NCT07589062","brief_title":"Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple Sclerosis","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"New York University Abu Dhabi","lead_sponsor_class":"OTHER","start_date":"2026-04-15","primary_completion_date":"2027-11-15","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07589062","external_url":"https://clinicaltrials.gov/study/NCT07589062"},{"nct_id":"NCT02446262","brief_title":"Neural and Psychological Mechanisms of Pain Perception","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Center for Complementary and Integrative Health (NCCIH)","lead_sponsor_class":"NIH","start_date":"2015-06-11","primary_completion_date":"2027-02-20","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT02446262","external_url":"https://clinicaltrials.gov/study/NCT02446262"},{"nct_id":"NCT05803785","brief_title":"Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Benobio Co., Ltd.","lead_sponsor_class":"INDUSTRY","start_date":"2025-07-01","primary_completion_date":"2026-12","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT05803785","external_url":"https://clinicaltrials.gov/study/NCT05803785"},{"nct_id":"NCT07589140","brief_title":"Influence of Alveolar Bone Drilling and Anatomical Position on Integration","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Lithuanian University of Health Sciences","lead_sponsor_class":"OTHER","start_date":"2026-04","primary_completion_date":"2028-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07589140","external_url":"https://clinicaltrials.gov/study/NCT07589140"},{"nct_id":"NCT07590622","brief_title":"EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"IRCCS San Raffaele","lead_sponsor_class":"OTHER","start_date":"2026-06","primary_completion_date":"2031-06","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590622","external_url":"https://clinicaltrials.gov/study/NCT07590622"},{"nct_id":"NCT07284654","brief_title":"Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"Vaxcyte, Inc.","lead_sponsor_class":"INDUSTRY","start_date":"2025-12-01","primary_completion_date":"2027-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07284654","external_url":"https://clinicaltrials.gov/study/NCT07284654"},{"nct_id":"NCT07497854","brief_title":"A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Pfizer","lead_sponsor_class":"INDUSTRY","start_date":"2026-10-01","primary_completion_date":"2030-07-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07497854","external_url":"https://clinicaltrials.gov/study/NCT07497854"},{"nct_id":"NCT06456346","brief_title":"Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Merck Sharp & Dohme LLC","lead_sponsor_class":"INDUSTRY","start_date":"2024-07-16","primary_completion_date":"2027-09-28","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06456346","external_url":"https://clinicaltrials.gov/study/NCT06456346"},{"nct_id":"NCT06707207","brief_title":"Predicting Future Errors During Skill Performance","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","lead_sponsor_class":"NIH","start_date":"2026-05-20","primary_completion_date":"2029-04-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06707207","external_url":"https://clinicaltrials.gov/study/NCT06707207"},{"nct_id":"NCT07509307","brief_title":"AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Novo Nordisk A/S","lead_sponsor_class":"INDUSTRY","start_date":"2026-04-20","primary_completion_date":"2028-08-14","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07509307","external_url":"https://clinicaltrials.gov/study/NCT07509307"},{"nct_id":"NCT07590284","brief_title":"Sonazoid CEUS for Early HCC Surveillance","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Tianjin Third Central Hospital","lead_sponsor_class":"OTHER","start_date":"2026-05-30","primary_completion_date":"2029-12-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590284","external_url":"https://clinicaltrials.gov/study/NCT07590284"},{"nct_id":"NCT06702033","brief_title":"The Minimalist Trial-2","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Washington University School of Medicine","lead_sponsor_class":"OTHER","start_date":"2025-04-10","primary_completion_date":"2030-04-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06702033","external_url":"https://clinicaltrials.gov/study/NCT06702033"},{"nct_id":"NCT07590323","brief_title":"BFR Training and Knee Osteoarthritis","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"University of Hail","lead_sponsor_class":"OTHER","start_date":"2026-06-15","primary_completion_date":"2026-12-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590323","external_url":"https://clinicaltrials.gov/study/NCT07590323"},{"nct_id":"NCT05889390","brief_title":"Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer","phase":"PHASE2,PHASE3","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"Semmelweis University","lead_sponsor_class":"OTHER","start_date":"2023-02-20","primary_completion_date":"2025-10-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT05889390","external_url":"https://clinicaltrials.gov/study/NCT05889390"},{"nct_id":"NCT07489378","brief_title":"NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Cancer Institute (NCI)","lead_sponsor_class":"NIH","start_date":"2026-05-20","primary_completion_date":"2035-04-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07489378","external_url":"https://clinicaltrials.gov/study/NCT07489378"},{"nct_id":"NCT07449325","brief_title":"Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"VahatiCor, Inc.","lead_sponsor_class":"INDUSTRY","start_date":"2026-04","primary_completion_date":"2026-11","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07449325","external_url":"https://clinicaltrials.gov/study/NCT07449325"},{"nct_id":"NCT07591324","brief_title":"the Objective of This Research is to Compare the Clinical Effectiveness of the Conventional Lingual Arch Space Maintainers With Three-dimensional Printed Space Maintainers.","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Suez Canal University","lead_sponsor_class":"OTHER","start_date":"2025-01-22","primary_completion_date":"2026-08-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07591324","external_url":"https://clinicaltrials.gov/study/NCT07591324"},{"nct_id":"NCT07160725","brief_title":"A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors","phase":"PHASE1,PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Bristol-Myers Squibb","lead_sponsor_class":"INDUSTRY","start_date":"2025-10-15","primary_completion_date":"2028-07-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07160725","external_url":"https://clinicaltrials.gov/study/NCT07160725"},{"nct_id":"NCT07191561","brief_title":"Hepatic Lipid Metabolism-Alcohol Use Disorder","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","lead_sponsor_class":"NIH","start_date":"2026-05-20","primary_completion_date":"2027-11-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07191561","external_url":"https://clinicaltrials.gov/study/NCT07191561"},{"nct_id":"NCT05630105","brief_title":"Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene","phase":null,"study_type":"OBSERVATIONAL","overall_status":"SUSPENDED","lead_sponsor_name":"Institut Bergonié","lead_sponsor_class":"OTHER","start_date":"2023-06-12","primary_completion_date":"2048-01","why_stopped":"Cyber attack of the enrollment system, new system on going to be implemented","last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT05630105","external_url":"https://clinicaltrials.gov/study/NCT05630105"},{"nct_id":"NCT00221650","brief_title":"Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University Hospital, Bordeaux","lead_sponsor_class":"OTHER","start_date":"2002-04","primary_completion_date":null,"why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT00221650","external_url":"https://clinicaltrials.gov/study/NCT00221650"},{"nct_id":"NCT07591285","brief_title":"A Study of SYS6051 in Subjects With Advanced Solid Tumors","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"CSPC Megalith Biopharmaceutical Co.,Ltd.","lead_sponsor_class":"INDUSTRY","start_date":"2026-05-12","primary_completion_date":"2028-05-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07591285","external_url":"https://clinicaltrials.gov/study/NCT07591285"},{"nct_id":"NCT07590557","brief_title":"Plyometrics for Strength and Function After Pediatric Burns","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Qassim University","lead_sponsor_class":"OTHER","start_date":"2024-04-01","primary_completion_date":"2025-03-25","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590557","external_url":"https://clinicaltrials.gov/study/NCT07590557"},{"nct_id":"NCT07377877","brief_title":"External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Cholecystectomy","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Karabuk University","lead_sponsor_class":"OTHER","start_date":"2026-01-01","primary_completion_date":"2026-04-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07377877","external_url":"https://clinicaltrials.gov/study/NCT07377877"},{"nct_id":"NCT07591480","brief_title":"Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"M.D. Anderson Cancer Center","lead_sponsor_class":"OTHER","start_date":"2026-05-01","primary_completion_date":"2026-10-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07591480","external_url":"https://clinicaltrials.gov/study/NCT07591480"},{"nct_id":"NCT07590479","brief_title":"Effects of White Noise and Lullaby on Vital Signs of Term Newborns in Neonatal Intensive Care","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Başakşehir Çam & Sakura City Hospital","lead_sponsor_class":"OTHER_GOV","start_date":"2025-09-30","primary_completion_date":"2025-12-20","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590479","external_url":"https://clinicaltrials.gov/study/NCT07590479"},{"nct_id":"NCT07589569","brief_title":"An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Shandong Suncadia Medicine Co., Ltd.","lead_sponsor_class":"INDUSTRY","start_date":"2026-05","primary_completion_date":"2028-12","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07589569","external_url":"https://clinicaltrials.gov/study/NCT07589569"},{"nct_id":"NCT06909253","brief_title":"Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"AstraZeneca","lead_sponsor_class":"INDUSTRY","start_date":"2025-05-15","primary_completion_date":"2029-12-31","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06909253","external_url":"https://clinicaltrials.gov/study/NCT06909253"},{"nct_id":"NCT07284641","brief_title":"Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Paul Szabolcs","lead_sponsor_class":"OTHER","start_date":"2026-05-04","primary_completion_date":"2030-05-04","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07284641","external_url":"https://clinicaltrials.gov/study/NCT07284641"},{"nct_id":"NCT07449091","brief_title":"Adaptability of an Undetectable = Untransmissible Model for HBV","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"NYU Langone Health","lead_sponsor_class":"OTHER","start_date":"2026-05-01","primary_completion_date":"2027-09","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07449091","external_url":"https://clinicaltrials.gov/study/NCT07449091"},{"nct_id":"NCT07000318","brief_title":"CS-206 in Patients With Sickle Cell Disease","phase":"EARLY_PHASE1","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Children's Hospital of Fudan University","lead_sponsor_class":"OTHER","start_date":"2026-09-30","primary_completion_date":"2028-12-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07000318","external_url":"https://clinicaltrials.gov/study/NCT07000318"},{"nct_id":"NCT07160335","brief_title":"A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Shanghai Henlius Biotech","lead_sponsor_class":"INDUSTRY","start_date":"2025-09-26","primary_completion_date":"2027-04-30","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07160335","external_url":"https://clinicaltrials.gov/study/NCT07160335"},{"nct_id":"NCT07558278","brief_title":"LINQ® Procedure vs. Conventional Medical Management for Sacroiliac Dysfunction","phase":"PHASE4","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"PainTEQ, LLC","lead_sponsor_class":"INDUSTRY","start_date":"2026-07-01","primary_completion_date":"2027-12-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07558278","external_url":"https://clinicaltrials.gov/study/NCT07558278"},{"nct_id":"NCT07590726","brief_title":"PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Rigshospitalet, Denmark","lead_sponsor_class":"OTHER","start_date":"2026-10-01","primary_completion_date":"2027-04-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07590726","external_url":"https://clinicaltrials.gov/study/NCT07590726"},{"nct_id":"NCT07137455","brief_title":"EDEN Intracardiac Electrogram Recording and Classifying System","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"ENROLLING_BY_INVITATION","lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","lead_sponsor_class":"NIH","start_date":"2026-05-20","primary_completion_date":"2026-11-01","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07137455","external_url":"https://clinicaltrials.gov/study/NCT07137455"},{"nct_id":"NCT06950606","brief_title":"Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","lead_sponsor_class":"OTHER","start_date":"2025-05-19","primary_completion_date":"2025-12-16","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT06950606","external_url":"https://clinicaltrials.gov/study/NCT06950606"},{"nct_id":"NCT04001699","brief_title":"Interprofessional Preoperative Geriatric Assessment for Older Arthroplasty Patients With Multimorbidity","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University of Eastern Finland","lead_sponsor_class":"OTHER","start_date":"2019-08-19","primary_completion_date":"2025-12-17","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT04001699","external_url":"https://clinicaltrials.gov/study/NCT04001699"},{"nct_id":"NCT07591558","brief_title":"The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis","phase":"EARLY_PHASE1","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"King Abdullah University Hospital","lead_sponsor_class":"OTHER","start_date":"2026-06","primary_completion_date":"2026-10","why_stopped":null,"last_update_date":"2026-05-15","url":"/api/v1/clinical/NCT07591558","external_url":"https://clinicaltrials.gov/study/NCT07591558"}]}